Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy

European Journal of Ophthalmology

Volumn 19, Issue 4, 2009, Pages 613-617

  Schaal, Karen B ^a   Hoeh, Alexandra E ^a   Scheuerle, Alexander ^a   Schuett, Florian ^a   Dithmar, Stefan ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Bevacizumab; Chronic central serous chorioretinopathy; Intraretinal fluid; Optical coherence tomography; Subretinal fluid

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; ARTICLE; CENTRAL SEROUS RETINOPATHY; CLINICAL ARTICLE; EYE EXAMINATION; FEMALE; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETINA FLUORESCEIN ANGIOGRAPHY; SUBRETINAL FLUID; VISUAL ACUITY;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CENTRAL SEROUS CHORIORETINOPATHY; CHRONIC DISEASE; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS; MALE; MIDDLE AGED; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 70549098654     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210901900415     Document Type: Article

References (22)

1. Hussain D, Gass JD. Idiopathic central serous chorioretinopathy. Ind J Ophthalmol 1998; 46: 131-7.
2. Klein ML, Van Burskirk EM, Freidman E, et al. Experience with nontreatment of central serous chorioretinopathy. Arch Ophthalmol 1974; 91: 247-50.
3. Pikkel J, Beiran I, Ophir A, Miller B. Acetazolamide for central serous chorioretinopathy. Ophthalmology 2002; 109: 1723-5.
4. Lafaut BA, Salati C, Priem H, De Laey JJ. Indocyanine green angiography is of value for the diagnosis of chronic serous chorioretinopathy in elderly patients. Graefes Arch Clin Exp Ophthalmol 1998; 236: 513-21.
5. Piccolino FC, Borgia L, Zinicola E, Zingirian M. Indocyanine green angiographic findings in central serous chorioretinopathy. Eye 1995; 9: 324-32.
6. Cohen D, Gaudric A, Coscas G, et al. Diffuse retinal epitheliopathy and central serous chorioretinopathy. J Fr Ophtalmol 1983; 6: 339-49.
7. Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular agere-lated macular degeneration. Ophthalmic Surg Lasers Imaging 2005; 36: 331-5.
8. Avery RL, Pieramici DJ, Rabena MD, et al. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 2006; 113: 363-72.
9. Rosenfeld PJ, Fung AE, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2005; 36: 336-9.
10. Manzano RP, Peyman GA, Khan P, Kivilcim M. Testing intravitreal toxicity of bevacizumab (Avastin). Retina 2006; 26: 257-61.
11. Bashshur ZF, Bazarbachi A, Schakal A, et al. Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 2006; 142: 1-9.
12. Schaal KB, Höh AE, Scheuerle A, et al. Bevacizumab for the treatment of macular edema secondary to retinal vein occlusion. Ophthalmologe 2007; 104: 285-9.
13. Ladas ID, Rouvas AA, Apostolopoulos M, et al. Diffuse retinal pigment epitheliopathy: treatment with laser photocoagulation. Eur J Ophthalmol 2004; 14: 315-20.
14. Yannuzzi LA, Slakter JS, Kaufman SR, Gupta K. Laser treatment of diffuse retinal pigment epitheliopathy. Eur J Ophthalmol 1992; 2: 103-14.
15. Watzke RC, Burton TC, Woolson RF. Direct and indirect laser photocoagulation of central serous chorioretinopathy. Am J Ophthalmol 1979; 88: 914-8.
16. Simon P, Glacet-Bernard A, Binaghi M, et al. Choroidal neovascularization as a complication following laser treatment of central serous chorioretinopathy. J Fr Ophtalmol 2001; 24: 64-8.
17. Taban M, Boyer DS, Thomas EL, Taban M. Chronic central serous chorioretinopathy: photodynamic therapy. Am J Ophthalmol 2004; 137: 1073-80.
18. Iida T, Kishi S, Hagimura N, Shimizu K. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina 1999; 19: 508-12.
19. Nielsen JS, Winreb RN, Yannuzzi L, Jampol LM. Mifepristone treatment of chronic central serous chorioretinopathy. Retina 2007; 27: 119-22.
20. Bouzas EA, Karadimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 2002; 47: 431-48.
21. Yoshioka H, Katsume Y. Experimental central serous chorioretinopathy. Ultrastructural findings. Jpn J Ophthalmol 1982; 26: 397-409.
22. Prünte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996; 9: 37-41.